Back
Protagonist Therapeutics Vs. Immuneering Industry Stock Comparison
Buy
54
PTGX
Protagonist Therapeutics
Last Price:
25.54
Seasonality Move:
28.29%
Sell
30
IMRX
Immuneering
Last Price:
1.56
Seasonality Move:
4.97%
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $25.54. The Score for PTGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Immuneering (IMRX)
is a Sell
Is Immuneering a Buy, Sell or Hold?
- The current Immuneering [IMRX] share price is $1.53. The Score for IMRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- IMRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $25.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
IMRX Stock Price Chart
What is Immuneering's stock price today?
-
The Immuneering share price today is $1.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMRX is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.78 | Sell |
| Relative Strength Index (14 RSI): | 42.33 | Sell |
| Chaikin Money Flow: | -6664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.53 - 28.19) | Sell |
| Bollinger Bands (100): | (23.22 - 29.1) | Sell |
IMRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 28.95 | Sell |
| Chaikin Money Flow: | 346027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.57 - 2.39) | Sell |
| Bollinger Bands (100): | (2.87 - 7.21) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.65 | Sell |
| 20-day SMA: | 26.49 | Sell |
| 50-day SMA: | 28.15 | Sell |
| 200-day SMA: | 21.88 | Buy |
| 8-day EMA: | 25.57 | Sell |
| 20-day EMA: | 26.33 | Sell |
| 50-day EMA: | 26.87 | Sell |
| 200-day EMA: | 23.56 | Buy |
IMRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.52 | Buy |
| 20-day SMA: | 1.82 | Sell |
| 50-day SMA: | 3.46 | Sell |
| 200-day SMA: | 6.43 | Sell |
| 8-day EMA: | 1.55 | Sell |
| 20-day EMA: | 1.92 | Sell |
| 50-day EMA: | 3.1 | Sell |
| 200-day EMA: | 5.76 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Immuneering Earnings Growth & IMRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.01 per share.
Protagonist Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Immuneering Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||